BioSpace News Archive

Securing long-term supply advances development of Company’s proprietary VMT-

ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test.

RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced that it has acquired DDS Lab.

Woolsey Pharmaceuticals, a clinical-stage company developing treatments for neurodegenerative diseases, today announced dosing of the first patient with BRAVYL in its FOUND (Fasudil fOr Uncontrolled waNDering) study for Alzheimer’s and Vascular Dementia patients who have wandering behaviors of elopement and/or getting lost.

Biocom California, the association representing the California life science industry, today announced that Enoch Kariuki, PharmD, chief financial officer of VelosBio, Bernard Parker, managing director of Caligen Bio, LLC, and Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics, have been added to its board of directors,

The National Foundation for Cancer Research (NFCR) announced today that the 2021 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to Tak W. Mak, Ph.D., senior scientist at the Princess Margaret Cancer Centre and university professor at the University of Toronto, and Mark M. Davis, Ph.D.,

Catalyst Solutions, an industry leader in strategic consulting and business process outsourcing for health plans, announced today that Scott Martin has been promoted to President, effective January 4, 2021.

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will host a conference call and webcast to discuss its fourth quarter and full year 2020 financial results on Thursday, February 25, 2021 at 4:30 p.m. ET.

Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that Carole Ben-Maimon, MD, President and Chief Executive Officer of Larimar Therapeutics, will present and participate in virtual 1x1 investor meetings at the SVB Leerink 10th Annual Global Healthcare Conference

Rx Redefined - a health tech company transforming the way physicians prescribe and patients obtain essential medical supplies - announced the successful completion of its $2M seed funding round, led by Silverton Partners with participation from Saturn Five.